ImpediMed Statistics
Total Valuation
ImpediMed has a market cap or net worth of 40.95 million. The enterprise value is 30.09 million.
| Market Cap | 40.95M |
| Enterprise Value | 30.09M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 2.03B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -99.65% |
| Shares Change (QoQ) | +98,809.32% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.83B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.73 |
| PB Ratio | 2.05 |
| P/TBV Ratio | 3.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.29 |
| EV / Sales | 4.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.57 |
| Quick Ratio | 4.19 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -283.40 |
Financial Efficiency
Return on equity (ROE) is -50.94% and return on invested capital (ROIC) is -33.93%.
| Return on Equity (ROE) | -50.94% |
| Return on Assets (ROA) | -29.71% |
| Return on Invested Capital (ROIC) | -33.93% |
| Return on Capital Employed (ROCE) | -68.12% |
| Revenue Per Employee | 86,065 |
| Profits Per Employee | -158,202 |
| Employee Count | 83 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, ImpediMed has paid 14,852 in taxes.
| Income Tax | 14,852 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.28% in the last 52 weeks. The beta is 2.34, so ImpediMed's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | -44.28% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 58.09 |
| Average Volume (20 Days) | 4,094 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ImpediMed had revenue of 7.14 million and -13.13 million in losses. Loss per share was -0.00.
| Revenue | 7.14M |
| Gross Profit | 6.28M |
| Operating Income | -14.38M |
| Pretax Income | -13.12M |
| Net Income | -13.13M |
| EBITDA | -13.38M |
| EBIT | -14.38M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 10.95 million in cash and 647,317 in debt, giving a net cash position of 10.30 million.
| Cash & Cash Equivalents | 10.95M |
| Total Debt | 647,317 |
| Net Cash | 10.30M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 20.00M |
| Book Value Per Share | 0.01 |
| Working Capital | 11.21M |
Cash Flow
| Operating Cash Flow | -11.32M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 87.88%, with operating and profit margins of -201.33% and -183.82%.
| Gross Margin | 87.88% |
| Operating Margin | -201.33% |
| Pretax Margin | -183.61% |
| Profit Margin | -183.82% |
| EBITDA Margin | -187.25% |
| EBIT Margin | -201.33% |
| FCF Margin | n/a |
Dividends & Yields
ImpediMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 99.65% |
| Shareholder Yield | n/a |
| Earnings Yield | -32.07% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ImpediMed has an Altman Z-Score of -0.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.01 |
| Piotroski F-Score | 3 |